The use of finasteride, a medication prescribed for male pattern baldness, has come under scrutiny due to its potential link to serious mental health issues. While it has been effective for many men experiencing hair loss, reports of side effects, including depression and suicidal thoughts, are prompting a critical examination among healthcare professionals and patients alike.
Understanding Finasteride and Its Mechanism
Finasteride is primarily used to treat androgenetic alopecia, known as male pattern baldness. The drug functions by inhibiting an enzyme that converts testosterone into dihydrotestosterone (DHT), a hormone responsible for hair follicle miniaturization, which leads to thinning hair. By blocking this enzyme, finasteride can reduce DHT levels by approximately 60–70% in most men.
First approved in the late 1990s, finasteride is typically administered as a daily oral tablet of 1 milligram. Higher doses of 5 milligrams are prescribed for non-cancerous prostate enlargement, but the medication is not intended for use by women, even though they may also experience hair loss.
Potential Mental Health Risks
Though changes in mental health are not officially listed as side effects in Australian guidelines for healthcare professionals, there is growing concern about the psychological impact of finasteride. Initial clinical trials did not indicate mental health risks, but subsequent patient monitoring has suggested a possible link to depression and suicidal ideation. This is particularly significant as the European Medicines Agency announced in May 2025 that suicidal thoughts are a confirmed side effect of the drug.
In addition, the U.S. Food and Drug Administration (FDA) issued a warning in April 2025 highlighting similar mental health risks associated with topical formulations of finasteride. This includes instances of depression, anxiety, and suicidal thoughts, raising alarms among health professionals and patients.
Patients experiencing mood changes while taking finasteride should consult a healthcare provider. It is crucial to address symptoms of depression or anxiety with medical guidance. In situations where symptoms are mild, a doctor may recommend pausing the medication to assess whether mood improvements occur. For more severe cases, discontinuing the drug and seeking immediate medical attention may be necessary.
If patients decide to stop taking finasteride, they can typically do so safely, as most side effects diminish once the medication is no longer in the system. However, some individuals have reported persistent symptoms. Stopping finasteride will lead to a gradual return to baseline hormone levels, and patients should be aware that hair regrowth benefits may be lost over time.
For those seeking alternatives, topical minoxidil is a well-established treatment for hair loss that can be obtained over the counter. While it may cause scalp irritation, its effectiveness is widely recognized. The incidence of depression and anxiety linked to minoxidil is lower than that associated with finasteride, primarily due to its topical application.
Another option is dutasteride, which functions similarly to finasteride. Given its comparable mechanism, it may also pose mental health risks, making it advisable for patients to avoid this medication if finasteride is unsuitable.
This growing body of evidence underscores the importance of ongoing dialogue between patients and healthcare providers regarding the risks and benefits of finasteride. As the conversation evolves, both the medical community and individuals dealing with hair loss must weigh the psychological implications alongside the potential for regrowth.
For those affected by this issue, seeking help is critical. If you or someone you know is struggling with mental health concerns related to medication, numerous resources are available, including crisis hotlines and mental health support services.
